Rebastinib (DCC-2036)

Product Specifications

CAS Number

1020172-07-9

SKU

C16967-50mg

Target

Bcr-Abl

Applications

Protein Tyrosine Kinase

Smiles

CC (C) (C) C1=NN (C (=C1) NC (=O) NC2=C (C=C (C=C2) OC3=CC (=NC=C3) C (=O) NC) F) C4=CC5=C (C=C4) N=CC=C5

Molecular Formula

C30H28FN7O3

Additionnal Information

Rebastinib (DCC-2036) is a conformational control Bcr-Abl inhibitor for Abl1 (WT) and Abl1 (T315I) with IC50 of 0.8 nM and 4 nM, also inhibits SRC, LYN, FGR, HCK, KDR, FLT3, and Tie-2, and low activity to seen towards c-Kit. Phase 1.

Storage Conditions

2 years -80 in solvent

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

C45926-01 50 μL

RL35A Antibody

Ask

View Details

C45926-02 100 µL

RL35A Antibody

Ask

View Details

GTR15215601 1 Vial

Lentiviral mouse P2rx3 shRNA (UAS) - Lentiviral mouse P2rx3 shRNA (UAS, GFP) (100)

Ask

View Details

A52606-50UG 50 µg

apaLIM Antibody

Ask

View Details

NB100-598V 0.1 mL

Mouse Monoclonal BRCA1 Antibody (RAY) [DyLight 405]

Ask

View Details

abx933941-01 15 nmol

Human SLC37A2 siRNA

Ask

View Details